| 0 (0%) | 12-27 00:23 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 39.08 | 1-year : | 45.64 |
| Resists | First : | 33.45 | Second : | 39.08 |
| Pivot price | 32.78  |
|||
| Supports | First : | 32.34 | Second : | 31.65 |
| MAs | MA(5) : | 32.78 |
MA(20) : | 32.88 |
| MA(100) : | 32.28  |
MA(250) : | 0 | |
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 49.2 |
D(3) : | 38.6 |
| RSI | RSI(14): 50.4 |
|||
| 52-week | High : | 33.7 | Low : | 28.76 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ PWS ] has closed below upper band by 41.1%. Bollinger Bands are 63.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 33.03 - 33.21 | 33.21 - 33.39 |
| Low: | 32.34 - 32.55 | 32.55 - 32.74 |
| Close: | 32.53 - 32.86 | 32.86 - 33.16 |
Wed, 24 Dec 2025
Liquidity Mapping Around (PWS) Price Events - Stock Traders Daily
Mon, 22 Dec 2025
Rhythm Pharmaceuticals: Early Promising PWS Data and Robust MC4R Pipeline Support Buy Rating and $140 Target - TipRanks
Mon, 22 Dec 2025
H.C. Wainwright raises Rhythm Pharmaceuticals stock price target on PWS trial data - Investing.com
Thu, 18 Dec 2025
PWS patients see weight loss, less hunger with setmelanotide in trial - Prader-Willi Syndrome News
Thu, 11 Dec 2025
Eye-tracking test adapted to better measure hunger behaviors in PWS - Prader-Willi Syndrome News
Thu, 11 Dec 2025
Professional Wireless Systems (PWS) Provides Comprehensive RF Support For 2025 Latin Grammy Awards in Las Vegas - Live Design Online
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|